page header

Contents  ·  Introduction  ·  Learning  Objectives  ·  Textbook  ·  Lectures  ·  Procedures  ·  Final Exam  ·  Library  ·  Laboratory  ·  Pharmacy  ·  Imaging  ·  Forms  ·  Videos  ·  About  ·  Contact Us>

Amantadine (Symmetrel)

Category:

  • Antiviral

Indications:

  • Influenza A virus respiratory tract illness

  • Influenza A prophylaxis

  • Parkinson’s disease

Precautions:

  • Pregnancy category C

  • Patients with a history of seizure should be closely monitored.

  • Patients with congestive heart failure (CHF) require careful observation and dose titration.

  • Dosing modification is required for patients with impaired renal function.

  • May cause CNS effects or blurred vision, therefore use caution while driving.

  • Do not discontinue medication abruptly, especially in patients with Parkinson’s disease.

  • Notify healthcare provider is mood or mental status changes occur.

  • Notify healthcare provider if anticholinergic side effects (difficult urination, dry mouth, constipation) occur.

  Adverse Reactions (Side Effects):

  • Nausea, dizziness, lightheadedness, insomnia (5-10%)

  • Blurred vision, headache

Dosage:

Administered as an oral capsule or syrup

Influenza A prophylaxis and acute treatment:

Adult:

  • 200mg qd or 100mg bid and continue for 24-48 hours after symptoms subside

Children (9-12 years):

  • 100mg bid

Children (1-9 years):

  • 4.4-8.8mg/kg/day given qd or divided twice daily (not to exceed 150mg per day)

 

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300  

Military Obstetrics & Gynecology
© 2003, 2004, 2005, 2006 Medical Education Division, Brookside Associates, Ltd.
All rights reserved

 


This information is provided by The Brookside Associates.  The Brookside Associates, LLC. is a private organization, not affiliated with any governmental agency. The opinions presented here are those of the author and do not necessarily represent the opinions of the Brookside Associates or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. All material presented here is unclassified.

C. 2009, 2014, All Rights Reserved

brookside associates logo

 

 

 

 

 

 

Advertise on this site